Research progress on novel intravitreal injection medications for the treatment of macular edema associated with retinal vascular diseases
Macular edema(ME)is a major complication of various vascular and inflammatory retinal diseases.While multiple conditions can lead to ME,diabetic retinopathy and retinal vein occlusion are the most common underlying causes.Elevated levels of vascular endothelial growth factor(VEGF)and inflammatory factors are two key pathogenic factors promot-ing ME formation.Consequently,intravitreal injections of anti-VEGF drugs and corticosteroids have become the primary treat-ment modalities for ME.This article discusses the latest progress of three recently approved novel drugs worldwide for the treat-ment of ME,aiming to provide reference for clinical application.
NETL
NSTL
万方数据
